Tumor progression stage could also be a factor, as most human adult tumors9 used in the comparison are late-stage tumors (nearly all of human breast tumors are invasive and 33% harbor TP53 mutation, while only half of the canine mammary tumors are invasive and <5% harbor TP53 mutation). This evidence concerns the gene TP53 and breast neoplasm.